By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor To Present At Leerink Partners Inaugural Immuno-Oncology Roundtable 9/25/2015 12:12:48 PM
Xencor's Partner Initiates Phase 2 Clinical Trial Of A Biologic Candidate Using XmAb Cytotoxic Fc Domain 9/24/2015 11:26:52 AM
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones 9/16/2015 5:54:39 AM
Xencor Reports Second Quarter 2015 Financial And Operating Results 8/5/2015 6:58:30 AM
Xencor To Present At 2015 Wedbush PacGrow Healthcare Conference 8/4/2015 9:14:36 AM
Xencor Appoints Yujiro S. Hata To Board Of Directors 7/31/2015 11:16:13 AM
Xencor To Host Second Quarter 2015 Financial Results Webcast And Conference Call On August 4, 2015 7/29/2015 9:49:38 AM
Xencor Provides Update On Two Lead XmAb Product Candidates And Expansion Of Bispecific Oncology Pipeline At R&D Day 6/26/2015 6:50:28 AM
Xencor To Host R&D Day And Webcast On June 26, 2015 6/12/2015 7:25:20 AM
Xencor Reports Complete Data Results On Xmab5871 Program At European League Against Rheumatism (EULAR) 2015 Annual Meeting 6/10/2015 6:34:22 AM